drugset / Trial / NCT03859024
Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty
RandomizedParallel-groupOpen-labelTreatment
Summary
The investigator's study aims to see if an enhanced recovery regimen of pain medications before and during surgery will decrease the use and risk of opioid pain medications as well as improve pain control in anterior urethroplasty patients. Participants will be randomized to one of two pain regimens (enhanced recovery regimen vs standard regimen).
Timeline
- Start
- 2019-03-22
- Primary completion
- 2023-04-30
- Completion
- 2023-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 0.5 % | — |
| Subject | Bupivacaine | Other / unclassified | 30 ml | — |
| Subject | Celecoxib | Other / unclassified | — | — |
| Subject | Dexamethasone | Small molecule | 4 mg | — |
| Subject | Gabapentin | Small molecule | — | — |
| Background | Acetaminophen | Small molecule | 1000 mg | — |
| Background | Ibuprofen | Small molecule | 800 mg | — |
| Background | Oxycodone | Other / unclassified | — | — |